| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.01 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |